Insiders Novartis AG London S.E.

Equities

Delayed London S.E. Other stock markets 16:59:30 21/05/2018 BST			5-day change	1st Jan Change
76.86 ^CHF	-1.00%		-0.77%	-.--%

06-24	Foreign banks target Switzerland after UBS takeover of Credit Suisse	RE
06-24	NOVARTIS AG : Barclays reaffirms its Sell rating	ZD

Nkarta, Inc. Appoints George Vratsanos as Board of Directors	06-13	CI
Chimeric Therapeutics Appoints COO; Shares Rise 4%	05-02	MT
Avacta picks Christina Coughlin to replace long-serving CEO	05-01	AN
Vas Narasimhan, CEO of Novartis: 40% margin by 2027	04-23	MT
Novartis Nominates Former Bristol Myers Squibb CEO as New Chair	04-23	MT
Novartis Lifts 2024 Guidance as First-quarter Earnings Grow on Strong Blockbuster Drug Demand	04-23	MT
Novartis Raises Guidance on Profit, Sales Growth	04-23	DJ
BioNTech Q4 Earnings, Revenue Fall; Sets 2024 Revenue Guidance -- Shares Drop Premarket	03-20	MT
BioNTech Names New Chief Commercial Officer	03-20	MT
Repeat & Correct : Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale -- Update	03-19	DJ
Pfizer to Raise Around $4.27 Billion From Haleon Shares Sale -- Update	03-19	DJ
Abivax appoints new head of quality	02-07	CF
Mondelez: Haleon CEO joins the Board of Directors	02-02	CF
GeNeuro appoints new Chief Medical Officer	01-08	CF
Top Stories at Midday: December US Nonfarm Payrolls Rise; ISM US Services Index Falls; CVS Names Finance Chief; Tesla to Recall Vehicles in China; Catalyst Prices Stock Offering	01-05	MT
Amgen Names James Bradner as Chief Scientific Officer	12-14	MT
Starpharma Names CEO	11-10	MT
Aura Biosciences Appoints New Chief Medical Officer	02/10/23	MT
Molecular Templates Names Chief Medical Officer	28/09/23	MT
ImmunoGen Names Lauren White CFO	18/09/23	MT